Protalix BioTherapeutics, Inc.
PLX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001006281
No open-market purchases or sales by Protalix BioTherapeutics, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $33.7M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Protalix BioTherapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- 0 vs. Q3 2022
- Shares held
- 3.57M
- +19.6K (+0.6%) vs. Q3 2022
- Total value
- $4.87M
- +$1.17M (+31.8%) vs. Q3 2022
- New holders
- 4
- 7 more added
- Sold out
- 4
- 4 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 101 | $33.7M |
| Q1 2026 | 100 | $36.6M |
| Q4 2025 | 83 | $26.8M |
| Q3 2025 | 77 | $30.9M |
| Q2 2025 | 63 | $17.6M |
| Q1 2025 | 63 | $21.0M |
| Q4 2024 | 46 | $8.40M |
| Q3 2024 | 45 | $3.53M |
| Q2 2024 | 66 | $6.60M |
| Q1 2024 | 64 | $11.9M |
| Q4 2023 | 66 | $17.6M |
| Q3 2023 | 61 | $15.2M |
| Q2 2023 | 66 | $17.9M |
| Q1 2023 | 34 | $6.15M |
| Q4 2022 | 26 | $4.87M |
| Q3 2022 | 27 | $3.70M |
| Q2 2022 | 30 | $1.30M |
| Q1 2022 | 32 | $1.29M |
| Q4 2021 | 31 | $2.45M |
| Q3 2021 | 35 | $5.91M |
| Q2 2021 | 33 | $8.24M |
| Q1 2021 | 38 | $39.4M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Protalix BioTherapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 120 | $164 | 0.00% | −10,998−98.9% | Reduced |
| Federation des caisses Desjardins du Quebec | 250 | $343 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 500 | $685 | 0.00% | +500 | New |
| Ten Capital Wealth Advisors, LLC | 1,000 | $1.37K | 0.00% | +110+12.4% | Added |
| Barclays PLC | 2,000 | $2.74K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,967 | $4.07K | 0.00% | −60−2.0% | Reduced |
| Federated Hermes, Inc. | 5,761 | $7.89K | 0.00% | 00.0% | Unchanged |
| Psagot Value Holdings Ltd. / (Israel) | 6,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 6,000 | $8.16K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 6,100 | $8.36K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 8,217 | $11.3K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 10,126 | $13.9K | 0.00% | −225−2.2% | Reduced |
| Smith, Salley & Associates | 12,048 | $16.5K | 0.00% | 00.0% | Unchanged |
| Altshuler Shaham Ltd | 12,478 | $17.1K | 0.00% | +12,478 | New |
| Two Sigma Advisers, LP | 20,600 | $28.2K | 0.00% | −4,700−18.6% | Reduced |
| Capital Performance Advisors LLP | 25,974 | $35.6K | 0.02% | 00.0% | Unchanged |
| IHT Wealth Management, LLC | 26,800 | $36.7K | 0.00% | +4,800+21.8% | Added |
| CIBC World Markets Inc. | 36,000 | $49.0K | 0.00% | +36,000 | New |
| Commonwealth Equity Services, LLC | 50,100 | $68.0K | 0.00% | +50,100 | New |
| Jane Street Group, LLC | 92,219 | $126.3K | 0.00% | +13,743+17.5% | Added |
| BlackRock Inc. | 101,893 | $139.6K | 0.00% | +3,130+3.2% | Added |
| Citadel Advisors LLC | 124,307 | $170.3K | 0.00% | +65,750+112.3% | Added |
| Bridgeway Capital Management, LLC | 133,790 | $183.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 224,603 | $308.0K | 0.00% | +107,403+91.6% | Added |
| Meitav Dash Investments Ltd | 244,482 | $318.8K | 0.01% | +150+0.1% | Added |
| Highbridge Capital Management LLC | 2,413,487 | $3.31M | 0.10% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −222,261−100.0% | Sold out |
| Davenport & Co LLC | 0 | $0 | 0.00% | −22,000−100.0% | Sold out |
| Aptus Capital Advisors, LLC | 0 | $0 | 0.00% | −13,957−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −373−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |